FI110186B - Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat - Google Patents

Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat Download PDF

Info

Publication number
FI110186B
FI110186B FI943386A FI943386A FI110186B FI 110186 B FI110186 B FI 110186B FI 943386 A FI943386 A FI 943386A FI 943386 A FI943386 A FI 943386A FI 110186 B FI110186 B FI 110186B
Authority
FI
Finland
Prior art keywords
formula
chlorophenyl
group
triazole
compound
Prior art date
Application number
FI943386A
Other languages
English (en)
Finnish (fi)
Other versions
FI943386A0 (sv
FI943386A (sv
Inventor
Leandro Baiocchi
Original Assignee
Angelini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angelini Ricerche Spa filed Critical Angelini Ricerche Spa
Publication of FI943386A0 publication Critical patent/FI943386A0/sv
Publication of FI943386A publication Critical patent/FI943386A/sv
Application granted granted Critical
Publication of FI110186B publication Critical patent/FI110186B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Claims (5)

1. Förfarande för framställning av ett terapeutiskt aktivt 2—{3— [4—(3-klorfenyl)-1-piperazinyl]propyl)-1,2,4- 5 triazol[4,3-a]pyridin-3-(2H)onderivat med formeln (I) I n n I R Cl
10 J (i) R' R" väri endast en av R, R', R'' och R'' ' är Ci-3-alkyl och de andra är H, och för f ramställning av syraadditionssalter 15 därav med fysiologiskt godtagbara, organiska eller oor-ganiska syror, kännetecknat av att en förening med formeln (III) 20 (III) ; J-NH o* : eller ett alkalimetallsalt därav bringas att reagera med en • 25 piperazinförening med formeln (II) • · « R" R'" Cl
30 T : väri R, R', R" och R' ' 1 är ovan definierade grupper och X är en sedvanlig avgaende grupp, som är en klor- eller bro-matom eller en grupp -0-S02Älk eller -0-S02Ar, väri Alk be- 35 tecknar en alkylgrupp och Ar betecknar en arylgrupp, i när-varo av ett lämpligt organiskt utspädningsmedel eller en • · 1 · r 1 110186 blandning av organiska utspädningsmedel vid en temperatur mellan 40 °C och reaktionsblandningens koktemperatur.
2. Förening som fungerar som mellanprodukt i fdrfa-randet enligt patent krav 1, kännetecknat av 5 att den har formeln (II) R" R"' Cl R' väri endast en av R, R', R'' och R'' ' är Ci_3-alkyl och de andra är H och X är en sedvanlig avgäende grupp, vilken är 15 en klor- eller bromatom eller gruppen -SC^Alk eller -SC>2Ar, väri Aik betecknar en alkylgrupp och Ar betecknar en aryl-grupp, och som är användbar som mellanprodukt i ett förfa-rande enligt patentkrav 1. I · » t * · * * • ·
9 I » ,
FI943386A 1992-01-17 1994-07-15 Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat FI110186B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI920084A IT1258790B (it) 1992-01-17 1992-01-17 Alchil derivati del trazodone
ITMI920084 1992-01-17
EP9300080 1993-01-14
PCT/EP1993/000080 WO1993014091A1 (en) 1992-01-17 1993-01-14 Alkyl derivatives of trazodone with cns activity

Publications (3)

Publication Number Publication Date
FI943386A0 FI943386A0 (sv) 1994-07-15
FI943386A FI943386A (sv) 1994-07-15
FI110186B true FI110186B (sv) 2002-12-13

Family

ID=11361589

Family Applications (2)

Application Number Title Priority Date Filing Date
FI943386A FI110186B (sv) 1992-01-17 1994-07-15 Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat
FI20021652A FI113266B (sv) 1992-01-17 2002-09-16 Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI20021652A FI113266B (sv) 1992-01-17 2002-09-16 Mellanproduktsföreningar som är användbara vid framställning av alkylderivat av trazodon

Country Status (25)

Country Link
EP (1) EP0623131B1 (sv)
JP (1) JP2856912B2 (sv)
KR (1) KR100254690B1 (sv)
AT (1) ATE136307T1 (sv)
AU (1) AU671973B2 (sv)
BG (1) BG61841B1 (sv)
BR (1) BR9305752A (sv)
CA (1) CA2128202C (sv)
CZ (1) CZ282910B6 (sv)
DE (1) DE69302087T2 (sv)
DK (1) DK0623131T3 (sv)
ES (1) ES2088270T3 (sv)
FI (2) FI110186B (sv)
GE (1) GEP20001939B (sv)
GR (1) GR3020420T3 (sv)
HU (5) HU218678B (sv)
IT (1) IT1258790B (sv)
NO (2) NO302365B1 (sv)
NZ (1) NZ246598A (sv)
PL (1) PL170913B1 (sv)
RO (1) RO113465B1 (sv)
RU (1) RU2126801C1 (sv)
SK (1) SK280561B6 (sv)
WO (1) WO1993014091A1 (sv)
ZA (1) ZA93292B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU718075B2 (en) * 1993-07-01 2000-04-06 Angelini Ricerche S.P.A. Societa Consortile Intermediates for the preparation of pharmacologically active enantiomers of triazolone compounds
IT1268414B1 (it) * 1993-07-01 1997-02-27 Angelini Francesco Ist Ricerca Enantiomeri farmacologicamente attivi
US7572808B2 (en) * 2005-06-17 2009-08-11 Bristol-Myers Squibb Company Triazolopyridine cannabinoid receptor 1 antagonists
ITMI20051193A1 (it) * 2005-06-24 2006-12-25 Acraf Uso farmaceutico di una 1-3-clorofenil-3-alchilpiperazina
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
RU2706700C1 (ru) 2019-09-24 2019-11-20 Общество с ограниченной ответственностью "Научно-производственная компания "СКиФФ" Фармацевтическая композиция для коррекции поведения кошек и собак в стрессовых ситуациях

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US100505A (en) * 1870-03-08 Improvement in sash-bolt
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione

Also Published As

Publication number Publication date
HU219493B (hu) 2001-04-28
AU3350493A (en) 1993-08-03
HU9402119D0 (en) 1994-09-28
CZ282910B6 (cs) 1997-11-12
HU217968B (hu) 2000-05-28
CZ173294A3 (en) 1995-02-15
CA2128202C (en) 2001-01-23
ZA93292B (en) 1993-08-19
NO302365B1 (no) 1998-02-23
HU9502179D0 (en) 1995-09-28
DK0623131T3 (da) 1996-08-05
ATE136307T1 (de) 1996-04-15
HUT71513A (en) 1995-12-28
SK280561B6 (sk) 2000-03-13
KR100254690B1 (ko) 2000-05-01
FI943386A0 (sv) 1994-07-15
WO1993014091A1 (en) 1993-07-22
ITMI920084A1 (it) 1993-07-17
RO113465B1 (ro) 1998-07-30
PL170913B1 (pl) 1997-02-28
FI20021652A (sv) 2002-09-16
CA2128202A1 (en) 1993-07-22
HUT72591A (en) 1996-05-28
NO942668D0 (no) 1994-07-15
ITMI920084A0 (it) 1992-01-17
HU217981B (hu) 2000-05-28
NZ246598A (en) 1997-08-22
IT1258790B (it) 1996-02-29
BR9305752A (pt) 1997-01-28
EP0623131B1 (en) 1996-04-03
RU2126801C1 (ru) 1999-02-27
JPH07503000A (ja) 1995-03-30
NO303686B1 (no) 1998-08-17
HU218678B (hu) 2000-10-28
HU9502180D0 (en) 1995-09-28
HU217982B (hu) 2000-05-28
DE69302087D1 (de) 1996-05-09
HU9502178D0 (en) 1995-09-28
EP0623131A1 (en) 1994-11-09
GR3020420T3 (en) 1996-10-31
HUT71511A (en) 1995-12-28
SK84694A3 (en) 1995-04-12
DE69302087T2 (de) 1996-11-28
JP2856912B2 (ja) 1999-02-10
HU9502177D0 (en) 1995-09-28
BG61841B1 (bg) 1998-07-31
NO974462L (no) 1994-09-16
NO942668L (no) 1994-09-16
RU94036769A (ru) 1997-04-20
BG98896A (bg) 1995-03-31
HUT70761A (en) 1995-10-30
GEP20001939B (en) 2000-02-05
HUT71512A (en) 1995-12-28
AU671973B2 (en) 1996-09-19
FI113266B (sv) 2004-03-31
ES2088270T3 (es) 1996-08-01
FI943386A (sv) 1994-07-15
NO974462D0 (no) 1997-09-26

Similar Documents

Publication Publication Date Title
FI93104C (sv) Analogiförfarande för framställning av terapeutiskt användbara substituerade imidazolylalkylpiperazin- och -diazepinderivat
FR2521561A1 (fr) Derives de benzisothiazole et benzisoxale piperazine
LU84011A1 (fr) 2-phenoxyalkyl-1,2,4-triazol-3-ones antidepressives
HU182629B (en) Process for preparing pharmaceutical compositions containing imidazole derivatives
WO1998033784A1 (en) 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
CZ20031596A3 (cs) Deriváty substituovaného 2-fenylaminoimidazolinfenylketonu jako IP antagonistická činidla
HUT71347A (en) Novel process for preparing chiral {[(2-bromoethyl)-amino]-methyl}-2-nitro-1h-imidazol-1-ethanol and related compounds
US5391552A (en) Diphenylpiperazine derivative and drug for circulatory organ containing the same
FI110186B (sv) Förfarande för framställning av terapeutiskt aktiva 2-{3-[4-(3-klorfenyl)-1-piperazinyl]propyl}-1,2,4-triazol[4,3-a]pyridin-3-(2H) onderivat
CS274405B2 (en) Method of 4-cyanopyridazines preparation
CA2527192C (fr) Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament
FI73980C (sv) Förfarande för framställning av (-)-2-/1-(2,6-diklorfenoxi)-etyl-/1,3- diazacyklopent-2-en
ZA200104269B (en) 4,5-azolo-oxindoles.
US5543563A (en) Alkyl derivatives of trazodone with CNS activity
US6699862B1 (en) Indolyl-2-phenyl bisamidines useful as antiproliferative agents
FI73420C (sv) Förfarande för framställning av farmakologiskt värdefulla anilino-1,2, 3-triazol-derivat.
PL175970B1 (pl) Nowe podstawione 2-hydroksy-3-[1-(1H-imidazol-4-ilo)-alkilo] benzenokarboksyimidoamidy, sposób ich wytwarzania i środek do leczenia oczu
JP2001524072A (ja) C.n.s.及び心臓に効果がある2−(1,2,4−トリアゾール−1−イル)−1,3,4−チアジアゾール誘導体
FR2473520A1 (fr) Nouveaux derives imidazolylethoxymethyliques du pyrazole, utiles notamment comme agents antimicrobiens, et leur procede de preparation
RO116899B1 (ro) DERIVATI DE 1,2,4-TRIAZOL[4,3-a]-PIRIDINONA SI PROCEDEU PENTRU PREPARAREA ACESTORA
BG60318B2 (bg) Метод за получаване на триазолил тиоамидни производни
US4105768A (en) Hypotensive substituted 1,2,4-triazoles
FR2855520A1 (fr) Nouveaux derives d'imidazoles, leur preparation et leur utilisation en tant que medicament

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: ANGELINI RICERCHE S.P.A.